Literature DB >> 12768234

Immunoparalysis as a cause for invasive aspergillosis?

Koen J Hartemink1, Marinus A Paul, Jan Jaap Spijkstra, Armand R J Girbes, Kees H Polderman.   

Abstract

Aspergillus infections are among the most feared opportunistic infections in humans. These organisms are ubiquitous in nature; protection against infection is usually provided by anatomical barriers and by the immune system. Tissue invasion by Aspergillus is uncommon, occurring primarily in the setting of immunosuppression. The prognosis of invasive aspergillosis is very poor. Although it is widely recognised that critically ill patients in the Intensive Care Unit (ICU) are at risk for nosocomial infections, it is not generally appreciated that such patients may also be at risk for opportunistic infections usually seen only in immunocompromised patients. This might be explained by a biphasic immunological pattern during sepsis: an early hyperinflammatory phase followed by an anti-inflammatory response, leading to a hypo-inflammatory state, the so-called compensatory anti-inflammatory response syndrome (CARS or immunoparalysis). We describe four patients admitted to our ICU for various reasons, without a history of abnormal immune function, who developed invasive pulmonary aspergillosis. We hypothesise that the occurrence of these opportunistic infections in our patients may have been due to immunoparalysis, and that perhaps all ICU patients with sepsis and multiple organ dysfunction syndrome (MODS) may be at risk for opportunistic infections such as aspergillosis as a result of this syndrome. Physicians treating critically ill patients in the ICU should be aware of the CARS/immunoparalysis syndrome and its potential to cause opportunistic infections, even in patients with normal immune function prior to ICU admission.

Entities:  

Mesh:

Year:  2003        PMID: 12768234     DOI: 10.1007/s00134-003-1778-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  21 in total

1.  Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.

Authors:  I Oren; N Haddad; R Finkelstein; J M Rowe
Journal:  Am J Hematol       Date:  2001-04       Impact factor: 10.047

Review 2.  Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review.

Authors:  J Rello; M E Esandi; D Mariscal; M Gallego; C Domingo; J Valles
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

3.  Sir Isaac Newton, sepsis, SIRS, and CARS.

Authors:  R C Bone
Journal:  Crit Care Med       Date:  1996-07       Impact factor: 7.598

4.  Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle.

Authors:  W J Kox; R C Bone; D Krausch; W D Döcke; S N Kox; H Wauer; K Egerer; S Querner; K Asadullah; R von Baehr; H D Volk
Journal:  Arch Intern Med       Date:  1997-02-24

Review 5.  Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF.

Authors:  K Matsushima; J J Oppenheim
Journal:  Cytokine       Date:  1989-11       Impact factor: 3.861

Review 6.  Spectrum of invasive pulmonary aspergillosis in immunocompetent patients with chronic obstructive pulmonary disease.

Authors:  G Thommi; G Bell; J Liu; K Nugent
Journal:  South Med J       Date:  1991-07       Impact factor: 0.954

7.  Outcome of ICU treatment in invasive aspergillosis.

Authors:  J J Janssen; R J Strack van Schijndel; E H van der Poest Clement; G J Ossenkoppele; L G Thijs; P C Huijgens
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

8.  Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease.

Authors:  D Pittet; T Huguenin; S Dharan; J Sztajzel-Boissard; G Ducel; J B Thorens; R Auckenthaler; J C Chevrolet
Journal:  Am J Respir Crit Care Med       Date:  1996-08       Impact factor: 21.405

Review 9.  The pathogenesis of sepsis.

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

Review 10.  Candida and Aspergillus infections in immunocompromised patients: an overview.

Authors:  R Saral
Journal:  Rev Infect Dis       Date:  1991 May-Jun
View more
  21 in total

1.  Invasive aspergillosis in the ICU: an emerging disease.

Authors:  Wouter Meersseman; Eric Van Wijngaerden
Journal:  Intensive Care Med       Date:  2007-07-24       Impact factor: 17.440

2.  Invasive pulmonary aspergillosis in a patient presenting with idiopathic systemic capillary leak syndrome.

Authors:  Manabu Hayama; Nobuaki Shime; Tadashi Mio
Journal:  BMJ Case Rep       Date:  2014-05-23

3.  Different Host Immunological Response to C. albicans by Human Oral and Vaginal Epithelial Cells.

Authors:  Ying Gao; Guanzhao Liang; Qiong Wang; Xiaodong She; Dongmei Shi; Yongnian Shen; Xiaohong Su; Xiang Wang; Wenmei Wang; Dongmei Li; Weida Liu
Journal:  Mycopathologia       Date:  2019-01-01       Impact factor: 2.574

4.  Aspergillus infections in transplant and non-transplant surgical patients.

Authors:  Stephen Davies; Christopher Guidry; Amani Politano; Laura Rosenberger; Matthew McLeod; Tjasa Hranjec; Robert Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2014-05-05       Impact factor: 2.150

5.  Downregulation of CD40 ligand response in monocytes from sepsis patients.

Authors:  Anna Sinistro; Cristiana Almerighi; Chiara Ciaprini; Silvia Natoli; Emanuele Sussarello; Sara Di Fino; Francesca Calò-Carducci; Giovanni Rocchi; Alberto Bergamini
Journal:  Clin Vaccine Immunol       Date:  2008-10-22

6.  Successful management of Aspergillus liver abscess in a patient with necrotizing fasciitis.

Authors:  Josef Rieder; Matthias Lechner; Cornelia Lass-Floerl; Michael Rieger; Ingo Lorenz; Hildegunde Piza; Hugo Bonatti
Journal:  Dig Dis Sci       Date:  2007-04-27       Impact factor: 3.487

Review 7.  Tracheobronchial manifestations of Aspergillus infections.

Authors:  Rafal Krenke; Elzbieta M Grabczak
Journal:  ScientificWorldJournal       Date:  2011-11-20

8.  A Protective Mechanism in Lungs of Rats Experimentally Infected with Aspergillus fumigatus.

Authors:  Yehia A-G Mahmoud; Abdulaziz Yahya Al-Ghamdi; Eman H F Abd El-Zaher
Journal:  Mycobiology       Date:  2011-03-23       Impact factor: 1.858

9.  Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome.

Authors:  José Garnacho-Montero; Rosario Amaya-Villar; Carlos Ortiz-Leyba; Cristóbal León; Francisco Alvarez-Lerma; Juan Nolla-Salas; José R Iruretagoyena; Fernando Barcenilla
Journal:  Crit Care       Date:  2005-03-11       Impact factor: 9.097

Review 10.  Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.

Authors:  Florence Ader; Anne-Lise Bienvenu; Blandine Rammaert; Saad Nseir
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.